SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Integra LifeSciences Holdings Corporation and Encourages Investors with Losses to Contact the Firm
News provided byACCESSWIRE
May 25, 2023, 11:10 PM ET
LOS ANGELES, CA / ACECSSWIRE / May 25, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Integra LifeSciences Holdings Corporation ("Integra" or "the Company") (NASDAQ:IART) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Integra filed a report with the SEC on May 23, 2023, stating that: "Integra LifeSciences Holdings Corporation (the "Company"), after consultation with the U.S. Food and Drug Administration (the "FDA"), initiated a voluntary global recall of all products manufactured in its Boston, Massachusetts facility (the "Boston facility") distributed between March 1, 2018 and May 22, 2023 (the "voluntary recall")." The Company added that it expects that the voluntary recall and manufacturing stoppage will have the greatest impact on the Tissue Technologies segment, including Private Label, and has revised guidance. For the second quarter, the Company expects reported revenues in the range of $372 million to $376 million and adjusted earnings per diluted share to be in the range of $0.55 to $0.59. While it is difficult to estimate at this time the impact of the voluntary recall for the full year, if the manufacturing stoppage continued through the remainder of 2023, the Company estimates full-year revenue and adjusted earnings per share guidance provided during the Company's April earnings announcement would be negatively affected by approximately $60 million and $0.35, respectively. Products manufactured at the Boston facility represent approximately 5% of the Company's consolidated revenues. The Company expects to provide updated details on its full-year guidance during its second quarter 2023 financial results conference call."
If you are a shareholder who suffered a loss, click here to participate.
We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at email@example.com.
The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
The Schall Law Firm
Brian Schall, Esq.
SOURCE: The Schall Law Firm
NOTE: This content is not written by or endorsed by "KFDX/KJTL", its advertisers, or Nexstar Media Inc.